His primary scientific interests are in Internal medicine, Positron emission tomography, Dementia, Neuroscience and Biomarker. His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Neurology and Cardiology. His Positron emission tomography research integrates issues from Stroke, Fractional anisotropy, Diffusion MRI and Pathology.
His Dementia study integrates concerns from other disciplines, such as Alternative medicine, International working group, Gerontology and Consensus conference. Jean-Paul Soucy has included themes like Healthy volunteers and Audiology in his Neuroscience study. The concepts of his Biomarker study are interwoven with issues in Alzheimer's disease and Cognitive decline.
Jean-Paul Soucy mostly deals with Internal medicine, Neuroscience, Pathology, Disease and Positron emission tomography. His biological study spans a wide range of topics, including Endocrinology, Oncology and Cardiology. His Neuroscience study incorporates themes from Cognitive decline and Amyloid.
His Pathology study combines topics in areas such as Metabotropic glutamate receptor 5, Metabotropic glutamate receptor, Vesicular acetylcholine transporter and Radioligand. His Positron emission tomography study is associated with Nuclear medicine. His work deals with themes such as Biomarker, Psychiatry and Alzheimer's disease, which intersect with Dementia.
Jean-Paul Soucy focuses on Neuroimaging, Dementia, Internal medicine, Disease and Neuroscience. His Neuroimaging research includes elements of Nightmare, Psychopathology, Clinical psychology, Cell biology and Random forest. His research in Dementia intersects with topics in Biomarker, Standardized uptake value, Alzheimer's disease and Default mode network.
His research integrates issues of Oncology and Cardiology in his study of Internal medicine. His Disease research incorporates elements of Human brain and Vulnerability. His Neuroscience research is multidisciplinary, relying on both Scaffold, Neuroinflammation, Early detection and Amyloid.
His main research concerns Dementia, Internal medicine, Positron emission tomography, Pathology and Neuroimaging. His Dementia research is multidisciplinary, incorporating elements of Neuroscience and Cohort. His studies in Internal medicine integrate themes in fields like Sleep in non-human animals and Cardiology.
His study in Positron emission tomography is interdisciplinary in nature, drawing from both Amyloid beta, Metabotropic glutamate receptor, Amyloid precursor protein, Radioligand and Hippocampal formation. His studies deal with areas such as Fluorodeoxyglucose, Metabotropic glutamate receptor 5, Entorhinal cortex and Epilepsy as well as Pathology. His study explores the link between Neuroimaging and topics such as Standardized uptake value that cross with problems in Endocrinology, Progressive supranuclear palsy, Distribution and Rasagiline.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Thomas K. Karikari;Tharick A. Pascoal;Tharick A. Pascoal;Nicholas J. Ashton;Shorena Janelidze.
Lancet Neurology (2020)
SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep
Martin Michaud;Jean-Paul Soucy;Allal Chabli;Gilles Lavigne.
Journal of Neurology (2002)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng;Tharick A. Pascoal;Sulantha Mathotaarachchi;Joseph Therriault.
Alzheimer's Research & Therapy (2017)
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
Serge Gauthier;Christopher Patterson;Howard Chertkow;Michael Gordon.
Canadian Geriatrics Journal (2012)
Striatal D2 Receptor Binding in Sleep Bruxism: A Controlled Study with Iodine-123-Iodobenzamide and Single-photon-emission Computed Tomography
F. Lobbezoo;J.-P. Soucy;J.Y. Montplaisir;G.J. Lavigne.
Journal of Dental Research (1996)
Abnormal metabolic network activity in REM sleep behavior disorder
Florian Holtbernd;Jean-François Gagnon;Ron B. Postuma;Yilong Ma.
Neurology (2014)
Effects of the D2 Receptor Agonist Bromocriptine on Sleep Bruxism: Report of Two Single-patient Clinical Trials
F. Lobbezoo;J.-P. Soucy;N.G. Hartman;J.Y. Montplaisir.
Journal of Dental Research (1997)
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder
S. Mazza;J. P. Soucy;P. Gravel;M. Michaud.
Neurology (2006)
The Temporal Dynamics of Poststroke Neuroinflammation: A Longitudinal Diffusion Tensor Imaging–Guided PET Study with 11C-PK11195 in Acute Subcortical Stroke
Alexander Thiel;Basia A. Radlinska;Caroline Paquette;Michael Sidel.
The Journal of Nuclear Medicine (2010)
Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism.
Gilles J. Lavigne;Jean-Paul Soucy;Frank Lobbezoo;Christiane Manzini.
Clinical Neuropharmacology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
McGill University
McGill University
University of Montreal
McGill University
McGill University
University of Montreal
McGill University
Concordia University
McGill University
Concordia University
Graz University of Technology
Universität Hamburg
University of Porto
Pennsylvania State University
Clark University
Michigan State University
McMaster University
Spanish National Research Council
University of Pecs
Emory University
King's College London
University of Navarra
Indiana University
University of Warwick
University of Illinois at Urbana-Champaign
New Jersey Institute of Technology